Social Media Analysis Reveals Hidden Side Effects of Popular Weight Loss Injections
Researchers have conducted a comprehensive analysis of internet forums to uncover lesser-known side effects associated with widely used weight loss injections. According to a new study published by Penn Engineering, irregular menstrual cycles and fever-like symptoms appear among the most concerning adverse effects that may not be fully captured during standard clinical trials.
Massive Data Analysis Uncovers Patient Concerns
The research team analysed more than 400,000 Reddit posts to identify issues linked to GLP-1 medications, specifically semaglutide (the active ingredient in Ozempic and Wegovy) and tirzepatide (found in Mounjaro and Zepbound). These appetite-suppressing drugs, which are also prescribed for diabetes management, are currently used by at least 1.6 million Britons, with an estimated 3.3 million more expected to seek prescriptions this year.
While these medications have been associated with various documented side effects including vision problems, cancer risk, muscle loss, and mental health concerns, clinical trials typically focus on the most common or severe reactions. The researchers specifically sought to identify symptoms that might be underreported in formal studies.
Menstrual Irregularities and Temperature Fluctuations Emerge as Key Concerns
The analysis revealed that changes to menstrual cycles for women and drastic temperature fluctuations such as chills and hot flashes warrant further investigation. Approximately 4 percent of Reddit users in the study reported menstrual irregularities, which can include missed periods, heavy bleeding, or cycles that vary significantly in length.
Sharath Chandra Guntuku, the study's senior author and Professor in Computer and Information Science, explained: 'Some of the side effects we found, like nausea, are well known, and that shows that the method is picking up a real signal. The underreported symptoms are leads that came from patients themselves, unprompted, and clinicians could potentially pay attention to them.'
Neil Sehgal, the study's first author and a doctoral student, noted that this proportion could be 'even higher' in female-only research, adding: 'We think that's a signal worth investigating.'
Broader Pattern of Side Effects Identified
The research noted that Reddit users tend to be predominantly male and based in the United States, yet the findings still revealed significant patterns. Overall, around 44 percent of users analysed reported at least one side effect, with the most common complaints being:
- Stomach issues including pain and feelings of sickness
- Fatigue as the second most frequently reported complaint
- Chills and feeling unusually cold
- Hot flashes and fever-like symptoms
Jena Shaw Tronieri, senior research investigator at Penn and study co-author, explained the potential mechanism: 'These drugs are thought to work by engaging part of the brain called the hypothalamus, which helps regulate a wide variety of hormones. That doesn't mean the medications are necessarily causing these symptoms, but it could suggest that reports of menstrual changes and body temperature fluctuations are worth studying more systematically.'
Social Media as a Complementary Research Tool
Lyle Ungar, a professor and co-author on the study, highlighted the limitations of traditional clinical trials: 'Clinical trials generally identify the most dangerous side effects of drugs but sometimes fail to find what symptoms patients are most concerned about. Even though social media is not necessarily representative, a large collection of posts may reflect additional concerns.'
Professor Ungar, who has long studied the use of social media to identify adverse drug effects, compared online patient communities to 'a neighbourhood grapevine' where 'people who are living with these medications are swapping notes with each other in real time, sharing experiences that rarely make it into a doctor's office visit or an official report.'
Cautious Interpretation and Need for Further Research
The researchers acknowledge they cannot definitively prove that GLP-1 drugs are causing these symptoms, but they believe their findings warrant further scientific scrutiny. Professor Guntuku emphasized: 'Clinical trials are the gold standard, but by design, they are slow. This is not a replacement for trials, but it can move much faster, and that speed matters when a drug goes from niche to mainstream almost overnight.'
Semaglutide first became available as a weight loss aid in the UK in 2018, and over the past five years, approximately 10.2 million prescriptions have been issued. The vast majority of users access the medication privately rather than through the NHS, with usage doubling between 2024 and 2025, highlighting the importance of comprehensive side effect monitoring as these drugs become increasingly mainstream.
